Barclays Portfolio holdings
Barclays is a British universal bank whose roots go back to 1690, when the Quakers John Freame and Thomas Gould started a goldsmith banking business in London. The Barclays name came into the business in 1736, when James Barclay, son-in-law of founder John Freame, became a partner. Barclays launched the UK's first credit card, Barclaycard, in 1966, and in 1967 put the world's first cash machine in a branch in Enfield. In 2008 Barclays bought the North American operations of Lehman Brothers, and in 2009 it sold its Barclays Global Investors unit, home of the iShares ETFs, to BlackRock. It runs five divisions: UK consumer banking, UK corporate banking, private banking and wealth management, an investment bank and a US consumer bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$17.5B |
| 2 |
NVIDIA
NVDA
|
+$2.7B |
| 3 |
Intel
INTC
|
+$1.98B |
| 4 |
Broadcom
AVGO
|
+$1.46B |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.11B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$35.8B |
| 2 |
Apple
AAPL
|
+$1.83B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$913M |
| 4 |
Microsoft
MSFT
|
+$856M |
| 5 |
Bank of America
BAC
|
+$792M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 49.47% |
| 2 | Technology | 19.84% |
| 3 | Consumer Discretionary | 7.61% |
| 4 | Financials | 5.61% |
| 5 | Communication Services | 3.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3276
Genco Shipping & Trading
GNK
$1.14B
| $667K | ﹤0.01% |
25,489
-3,795
| -13% | -$98.8K |
2017 Q2
37 quarters
|
|
3277
Invesco Senior Loan ETF
BKLN
$5.81B
| $666K | ﹤0.01% |
32,587
-6,845,642
| -100% | -$140M |
2025 Q4
3 quarters
|
|
3278
CALL
Sarepta Therapeutics
SRPT
$1.79B
| $665K | ﹤0.01% |
+36,500
| New | +$683K |
2026 Q3
0 quarters
|
|
3279
Apogee Enterprises
APOG
$1B
| $665K | ﹤0.01% |
18,800
+4,009
| +27% | +$159K |
2013 Q2
53 quarters
|
|
3280
Bausch Health
BHC
$3.13B
| $663K | ﹤0.01% |
113,682
+19,818
| +21% | +$114K |
2013 Q2
53 quarters
|
|
3281
Blackstone Digital Infrastructure Trust
BXDC
$1.69B
| $663K | ﹤0.01% |
38,213
+34,303
| +877% | +$692K |
2026 Q2
1 quarter
|
|
3282
CALL
Absci
ABSI
$1.74B
| $661K | ﹤0.01% |
61,400
| – | – |
2026 Q2
1 quarter
|
|
3283
AngioDynamics
ANGO
$522M
| $660K | ﹤0.01% |
42,932
+10,473
| +32% | +$156K |
2013 Q2
53 quarters
|
|
3284
QXO Inc
QXO
$14.3B
| $659K | ﹤0.01% |
56,400
-311,948
| -85% | -$4.29M |
2024 Q4
7 quarters
|
|
3285
BBVA Argentina
BBAR
$2.18B
| $659K | ﹤0.01% |
51,254
-2,965
| -5% | -$49.3K |
2025 Q3
4 quarters
|
|
3286
CALL
SharonAI Holdings
SHAZ
$946M
| $655K | ﹤0.01% |
12,000
| – | – |
2026 Q2
1 quarter
|
|
3287
JOYY Inc
JOYY
$3.95B
| $655K | ﹤0.01% |
8,159
+5,017
| +160% | +$373K |
2022 Q1
18 quarters
|
|
3288
DELISTED
BioLife Solutions
BLFS
| $654K | ﹤0.01% |
16,844
-10,873
| -39% | -$368K |
2018 Q3
32 quarters
|
|
3289
Cogent Communications
CCOI
$227M
| $653K | ﹤0.01% |
83,824
+55,530
| +196% | +$594K |
2013 Q2
53 quarters
|
|
3290
Heritage Financial
HFWA
$1.14B
| $651K | ﹤0.01% |
23,578
+1,560
| +7% | +$45.6K |
2016 Q2
41 quarters
|
|
3291
Palvella Therapeutics
PVLA
$2.4B
| $649K | ﹤0.01% |
4,707
+1,914
| +69% | +$284K |
2017 Q2
37 quarters
|
|
3292
CALL
Birkenstock
BIRK
$6.05B
| $648K | ﹤0.01% |
20,000
| – | – |
2026 Q2
1 quarter
|
|
3293
Caleres
CAL
$464M
| $644K | ﹤0.01% |
52,875
+5,757
| +12% | +$72.6K |
2013 Q2
53 quarters
|
|
3294
Corsair Gaming
CRSR
$1.39B
| $643K | ﹤0.01% |
47,633
+32,655
| +218% | +$378K |
2022 Q1
18 quarters
|
|
3295
Cabaletta Bio
CABA
$313M
| $642K | ﹤0.01% |
334,450
+289,749
| +648% | +$817K |
2022 Q1
18 quarters
|
|
3296
Prime Medicine
PRME
$780M
| $639K | ﹤0.01% |
209,218
+121,160
| +138% | +$402K |
2022 Q4
15 quarters
|
|
3297
American Exceptionalism Acquisition Corp
AEXA
$526M
| $639K | ﹤0.01% |
57,360
| – | – |
2026 Q1
2 quarters
|
|
3298
Expensify
EXFY
$164M
| $638K | ﹤0.01% |
283,693
+194,767
| +219% | +$419K |
2023 Q1
14 quarters
|
|
3299
Wolverine World Wide
WWW
$1.8B
| $638K | ﹤0.01% |
33,399
+20,515
| +159% | +$394K |
2016 Q1
42 quarters
|
|
3300
PUT
X-Energy Inc
XE
$3.14B
| $638K | ﹤0.01% |
45,000
| – | – |
2026 Q2
1 quarter
|
|
Similar funds
Barclays's Q3 2026 Portfolio in Review
As of Q3 2026, Barclays held 5,855 positions worth $500B, down 4% from $521B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Barclays withdrew a net $19B in Q3 2026, closing 474 positions and reducing 1,494 holdings. Its most notable exit was ExxonMobil, an estimated $761M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 49% of assets, down from 55% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Barclays opened a new position in iShares Broad USD High Yield Corporate Bond ETF worth $199M.
- Barclays's largest Q3 2026 buy was iShares Broad USD High Yield Corporate Bond ETF: 5,582,517 shares worth $199M.
- Barclays added most to Tesla in Q3 2026, an estimated $17.5B increase.
- Barclays's biggest Q3 2026 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $35.8B.
- Barclays fully exited ExxonMobil in Q3 2026, selling an estimated $761M.
- Barclays's ten largest holdings make up 40% of its $500B portfolio in Q3 2026.
- Barclays opened 525 new positions and closed 474 in Q3 2026.
- Barclays's portfolio value fell 4% quarter-over-quarter to $500B.
Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.